Key facts
- DCDC Kidney Care’s last known valuation is $65.8M (Mar 2025).
- It has raised $59.7M; the latest was PE Growth/Expansion ($17.3M) in Mar 2025.
- Notable investors include British International Investment, Impact Fund Denmark, Asian Development Bank, ABC Impact.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for DCDC Kidney Care
- ·The full record, as it builds
Funding rounds
No funding rounds for DCDC Kidney Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DCDC Kidney Care
Operator of a network of dialysis centers intended for patients suffering from end-stage renal disease (ESRD). The company offers services such as patient counseling, preventive nephrology, in-center hemodialysis and peritoneal dialysis as well as at-home dialysis services, enabling patients suffering from renal diseases to begin treatment quickly and reliably.
- Sector
- Healthcare
- HQ
- New Delhi, India
- Founded
- 2009
- Employees
- 1,000
- Website
- dcdc.co.in/
- Ownership
- Privately Held (backing)
DCDC Kidney Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DCDC Kidney Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DCDC Kidney Care in its N-PORT filings yet. We sweep new filings monthly.